Henry Schein, Inc.HSICNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

businesswire.com

A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program

HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children's lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National C.

businesswire.com

Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the B.

defenseworld.net

Dilation Capital Management LP Invests $5.11 Million in Henry Schein, Inc. $HSIC

Dilation Capital Management LP bought a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 76,920 shares of the company's stock, valued at approximately $5,105,000. Henry Schein accounts for 2.5% of

businesswire.com

Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer

IRVINE, Calif.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care.

seekingalpha.com

Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

zacks.com

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

businesswire.com

Henry Schein Names Frederick M. Lowery as Chief Executive Officer

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef.

zacks.com

HSIC or SAUHY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?

defenseworld.net

Critical Analysis: McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ: HSIC - Get Free Report) and McKesson (NYSE: MCK - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Risk and Volatility Henry Schein has a beta of

fool.com

One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan

Chicago-based Zuckerman Investment Group increased its Henry Schein position by 72,040 shares in the third quarter. The overall position value went up by about $3.38 million from the previous period.

businesswire.com

Henry Schein to Participate in the J.P. Morgan Conference in January

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January: J.P. Morgan's Healthcare Investor Conference on Tuesday, January 13, 2026, at 3:00 p.m. PST / 6:00 p.m. EST, at The Westin St. Francis hotel in San Francisco. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.c.

defenseworld.net

Assenagon Asset Management S.A. Decreases Stock Position in Henry Schein, Inc. $HSIC

Assenagon Asset Management S.A. decreased its holdings in Henry Schein, Inc. (NASDAQ: HSIC) by 52.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,480 shares of the company's stock after selling 23,586 shares during the period. Assenagon Asset Management

businesswire.com

Henry Schein Provides Update on CEO Search Process

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company's next CEO by mid-January 2026. Philip A. Laskawy, Lead Director for Henry Schein said, “We are pleased with the progress we have made in our search for Henry Schein's next CEO. The search process is nearing completion but will not be finalized before year.

schaeffersresearch.com

Stock Futures Cool Off After Delayed GDP Data

Stock futures are quietly lower as investors unpack previously delayed GDP data for the third quarter

defenseworld.net

McKesson (NYSE:MCK) vs. Henry Schein (NASDAQ:HSIC) Critical Analysis

Henry Schein (NASDAQ: HSIC - Get Free Report) and McKesson (NYSE: MCK - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Valuation and Earnings This table compares Henry Schein and

defenseworld.net

Arrowstreet Capital Limited Partnership Has $21.12 Million Holdings in Henry Schein, Inc. $HSIC

Arrowstreet Capital Limited Partnership grew its stake in Henry Schein, Inc. (NASDAQ: HSIC) by 80.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 289,051 shares of the company's stock after purchasing an additional 129,077 shares during the period. Arrowstreet Capital

seekingalpha.com

Henry Schein Can Make Your Portfolio Smile

Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver solid growth, reporting Q3 revenue up 5.2% year-over-year and improved profitability across all segments, driven by internal growth and targeted programs. Management anticipates ongoing revenue and EBITDA growth, supported by demographic trends, increased healthcare access, and technological advancements like AI in dental care.

Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report?

zacks.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance